What is the category of COVID-19 patients that require plasma therapy? Is there any category of patients who cannot undertake it, because of other health complications?
People who have moderate to severe illness are the right candidates for treatment through plasma therapy. Medically, I would say people who have pneumonia with type I respiratory failure and acute respiratory distress syndrome (ARDS) are the category of patients for this treatment. Patients with mild illness do not require plasma therapy and the treatment is futile in patients with very critical illness with multi-organ failure. There are no other medical conditions under which a patient cannot get this treatment.
How effective is the therapy?
Obviously, it is not a magic bullet and not 100% effective. It is one of the good treatment options available because as of now we do not have any definitive treatment for COVID-19. Most of the therapies are either experimental or have some effectiveness. This is one of the promising therapies, however, it is not an established treatment. More studies are needed to confirm its effectiveness but small studies have merged from the US- they are series of 5-patient report or 10-patient report.
In one series of 5-patient report, all 5 patients on ventilator have successfully come out of it and in another 10 series patients, they found the virus clearing happened rapidly after giving plasma treatment. Therefore, reports like these coupled with our first successful case where the patient responded well to the treatment indicate that plasma therapy is potentially effective therapy. However, larger studies need to be conducted to really say how effective it is.
How is the procedure conducted?
Diese Geschichte stammt aus der May 2020-Ausgabe von Healthcare Radius.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der May 2020-Ausgabe von Healthcare Radius.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Dengue-related searches surge on Justdial
Justdial data reveals significant increase in dengue-related searches and pest control services this monsoon season, amid severe dengue outbreak in India.
Ipca launches NovaLead's Diulcus for diabetic foot ulcer
Ipca Laboratories launches NovaLead's patented drug Diulcus, for the treatment of diabetic foot ulcer in India.
Sahyadri Hospitals unveils advanced radiotherapy treatment
Sahyadri Hospitals launches Asia's first advanced radiotherapy treatment, Radixact X9 system with Vital Hold technology for precise cancer treatment.
Complex liver transplant saves diabetic patient
Wockhardt Hospitals, Mumbai Central and South Asian Liver Institute provide liver transplant services to a Botswanian patient.
Gynecological cancers rise in young Indian women
Experts stress need for awareness, early screening, and advanced treatment options like robotic-assisted surgery for gynecological cancers.
Mahajan Imaging, Siemens unveil AI diagnostic analyzer
Mahajan Imaging and Labs and Siemens Healthineers launch India's first Al-diagnostic analyzer.
Nimotuzumab boosts head and neck cancer survival - Tata Memorial study
A Tata Memorial study finds Nimotuzumab increases 10-year survival rate for head and neck cancer patients.
Kolkata doctor rape and murder: Everything you wanted to know
Protesting doctors demand better workplace safety and stricter policy measures.
AYUSH treatments to be covered under PM-JAY?
Very soon, AYUSH treatments may be covered under AB PM-JAY.
WHAT DOCTORS MUST TELL PATIENTS ABOUT DRY EYE SYNDROME
Dry eye syndrome affects lakhs of people globally, causing discomfort and vision issues. Learn how doctors must guide patients about managing it.